Logo BadenCampus Logo university of Basel Logo life science accelerator Logo semia incubator Logo innovact Logo quai Alpha Logo rimbaud tech Logo quest for change Logo startup bw Logo the pool

Get in touch with Corporates, Manufacturers and investors

Organised by BadenCampus together with its partners from the Life Science Accelerator Baden-Württemberg, SEMIA (member of the Quest for change network) and the University of Basel, the ‘Trinational HealthTech Days #2’ business event aims to connect innovative startups and the ecosystems from France, Germany and Switzerland to promote international cooperation in the health technology sector (biotech, medtech, digital health) with a dual challenge:

  • a better understanding of the opportunities for startups to gain access to clinics in order to validate and test their products and services.
  • a better understanding of how corporates work together with startups to improve their chances of success.
  • the opportunity to network with international startups and connect with funds, VCs and corporate investors.

Take a look at last year's page 


13th October - Day 1

Market access strategy for health products and country particularities


14:00 – 14:15   

Opening remarks


Dr. Thomas Scheuerle, Managing Director at BadenCampus

Dr. Guillaume Vetter-Genoud, Head of deeptech/healthcare, SEMIA

Maarten van Winckel, Startup Community & Initiatives at University of Basel 

Bodo Brückner, Startup Advisor; Coordinator Lifescience Accelerator Baden-Wuerttemberg

Markus Bühler, Coordinator Lifescience Accelerator Baden-Wuerttemberg


14:15 – 15:00

Session A (for Digital health/Medtech Startups) How to access clinics as a startup?
From the 1st experimentations until the clinical trials.

This session will shed some light on how startup teams can get access to hospitals. To this end the speakers will present different approaches and strategies ranging from consultancy services to whole clinical departments including patient, nurses and doctors interacting with teams.

Moderator: Bodo Brückner


Annegret Genger, Senior Consultant Regulatory and Clinical Affairs at Seleon

Mirjam Schleske, Organisational Management INSPIRE Living Lab

Dr. Christian Haverkamp, Acting Director, "Institut für Digitalisierung in der Medizin" at Uniklinik Freiburg

Matis Ringdal, CEO at Pixacare

Olivier Terenzi, Clinical research project manager at OMEOS

15:00 – 15:15


14:15 – 15:00

Session B (for Biotech Startups)
When and how to start discussing with major corporates / big pharma as Start up?

This session will, in a very open manner, address topics relevant for start-ups wanting to collaborate with corporates / big pharma. What do you need to consider to maximize your chances for collaboration and when is the best time in your journey to think about this endeavor, are just a few of the questions that will be addressed during this session.

Moderator: Maarten Van Winckel


Samantha Brandler, Head of Research Innovation, Europe at CSL Behring

Michael R Huebner, Director Early Innovation Partnering at Johnson and Johnson

Ashley Nagle, Vice President of Business Development at RemedyBio

Jonathan Butcher, Head of Business Development and Alliance Management at BioVersys

15:00 - 15:15


GENERAL TALK: 15:25 – 16:25

15:25 – 16:10

Successful access and cooperation

How does the successful acquisition of a significant investment work, what are the main hurdles after the first access in clinics and how can corporates and startups work together to accelerate this journey?

Moderator: Malaika Lauk


Christian Kraft, Director Corporate Development - External Innovation at B. Braun Innovation Hub & Managing Director CeCaVa GmbH & Co. KG

Dr. Michael Luettgen, Liason Manager at German EIT Health GmbH

Dipl.-Ing. Catherine Schreiber, deputy CEO & COO at ADVITOS GmbH

16:10 - 16:25


CLOSING REMARKS: 16:25 – 16:40

16:25 – 16:40   

Closing remarks

14th October - Day 2

One-on-One meetings of startups and investors/corporates

INSTRUCTIONS: 14:00 – 14:15

14:00 – 14:15   

Opening & Instructions

ONE-ON-ONE SESSIONS: 14:15 – 17:00

14:15 – 17:00

One-on-One sessions 


Bodo Brückner

Startup Advisor; Coordinator Lifescience Accelerator Baden-Wuerttemberg

Markus Buehler

Coordinator Lifescience Accelerator Baden-Wuerttemberg

Amélie Gallego

Head of Communication, SEMIA

Dr. Yves Gendrault

Public research projet manager at SEMIA

Dr. Romain Neidl

PhD, MSc - Healthcare Business manager, SEMIA

Dr. Thomas Scheuerle

Managing Director, BadenCampus

Dr. Katerina Tsouroula

PhD, MSc - Digital health Business manager, SEMIA

Maarten Van Winckel

Startup Community & Initiatives, University of Basel

Dr. Guillaume Vetter-Genoud

PhD, MBA - Head of deeptech / healthcare, SEMIA

Linda Wistup

Room, community and event / trainer, BadenCampus

Business Angels